The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Please consider posting comments about Poolbeg on the POLB chat forum.
This forum is for ORPH.
A further 42.65 thousand pound transaction at 2pm auction @14.60p
As regular as clockwork.
troutisout
Spot on.
and yes, definitely a consistant buyer through auction.
Price being held back to satisfy a buyer IMO.
Annoying, but actually a very good thing.
It's becoming a regular occurence to witness a decent auction period falling in favour of a stronger SP.
Today's contract is with a NEW client - German-based Biotec Co.
Nice.
Not just adding contracts, but adding clients also.
Multi-million contract win with a leading biotechnology company.
Coming soon: director share purchase, full yr results, confimation ref NOMAD.
Quoted.
And it’s this part of the business that new chief executive Mo Khan predicts will be the driver of growth for the company that wants to be a “true” specialist contract research organisation, and one increasingly recognised by ‘Big Pharma’ and biotechs as the world leader in vaccine and antiviral testing using human challenge clinical trials.
Orphan’s early foray into Covid challenge studies has extended to malaria bringing the total challenge models to eight, and Khan talks about at least one good phone call a week from clients relating to one or all of the company’s capabilities and capacity.
Just purchased 186269k shares over three trades.
Nice to be back.
The 39.17 was after hours trade = £600+
Google displays the trade,
Merck Sharp & Dohme Corp [sub of Merck] hold 4.65 percent stake in 4d - which they announced March 2021.
Any thoughts around why they haven't extended their position further?
I've emailed IR at 4d.
Let's see if a response is forthcoming.
Looking very good, thus far - today.
More volume, please :)
39.15 - 39.95 (GBX) at 13:01:58
Looking better. Doesn't take much :)
Also, keep your eyes on the volume for today.
Interesting price action, similar to 12th April prior to 35 percent rise to 55p.
Watch today's close. Wouldn't be surprised to see this close above 41p.
If we close below 40p then we may have to wait a short while longer :)
Simple answer : Yes.
Bodes well for the week ahead.
Nice to see SP stronger at close - e.g. not losing strength during afternoon
Very good.
SP all over the place but looking [as i type] very strong in to close period.
Looks like we're coming around to see 49p - Target 1